Wave Life Sciences Ltd. (WVE)
NASDAQ: WVE · Real-Time Price · USD
7.66
-0.53 (-6.47%)
Oct 10, 2025, 2:32 PM EDT - Market open

Wave Life Sciences Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2024FY 2023FY 2022FY 2021FY 20202015 - 2019
Period Ending
Oct '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 2015 - 2019
1,2201,887602608185384
Upgrade
Market Cap Growth
18.93%213.59%-1.10%229.32%-51.88%39.68%
Upgrade
Enterprise Value
1,0651,61150353395206
Upgrade
Last Close Price
8.1912.375.057.003.147.87
Upgrade
PS Ratio
13.5317.425.31166.724.5119.12
Upgrade
PB Ratio
9.158.6812.67-16.354.584.24
Upgrade
P/TBV Ratio
8.999.0115.18-5.684.64
Upgrade
EV/Sales Ratio
11.3314.874.44146.022.3310.24
Upgrade
Debt / Equity Ratio
0.150.120.68-1.010.740.32
Upgrade
Asset Turnover
0.410.350.540.020.170.07
Upgrade
Quick Ratio
2.402.741.191.242.351.77
Upgrade
Current Ratio
2.562.891.261.382.531.90
Upgrade
Return on Equity (ROE)
-171.41%-73.24%-1118.17%-10258.19%-186.60%-184.78%
Upgrade
Return on Assets (ROA)
-38.90%-22.00%-20.17%-57.56%-32.65%-34.02%
Upgrade
Return on Capital (ROIC)
-88.75%-42.80%-106.22%-287.75%-83.45%-85.55%
Upgrade
Earnings Yield
-10.38%-5.14%-9.56%-26.60%-66.17%-39.05%
Upgrade
FCF Yield
-15.99%-8.05%-3.42%-21.23%-48.48%-30.56%
Upgrade
Buyback Yield / Dilution
-30.52%-30.33%-34.55%-52.16%-32.12%-15.83%
Upgrade
Updated Jul 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q